Silver Book Fact

Every $1 spent on technological innovations in heart attack care has produced an estimated $7 gain.

Cutler D, McClellan M. Is Technological Change in Medicine Worth It?. Health Affairs. 2001; 20(5): 11-29. http://content.healthaffairs.org/content/20/5/11.full

Reference

Title
Is Technological Change in Medicine Worth It?
Publication
Health Affairs
Publication Date
2001
Authors
Cutler D, McClellan M
Volume & Issue
Volume 20, Issue 5
Pages
11-29
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • The percentage of Americans age 55-64 with high cholesterol decreased between 1988-94 and 1999-2002, in part because of the increased awareness about the risks of high cholesterol and the increased…  
  • Glycoprotein inhibitors have been shown to reduce the risk of death, a second heart attack, or the need for revascularization by 48% to 52% in patients who have suffered a…  
  • Cost of warfarin therapy for AFib patients
    In patients with nonvalvular atrial fibrillation (AF) and one additional stroke risk factor, warfarin therapy cost $8,000 per quality-adjusted life-year (QALY) saved.  
  • Treatment for hypertension using antihypertensive therapy has generated a benefit-to-cost ratio of at least 6:1.  
  • Pioglitazone associated with relative risk reduction in recurrent stroke
    The PROactive trial to manage glucose in diabetics with a history of cardiovascular disease, stroke, or other vascular risk factors found that treatment with pioglitazone was associated with a 47% relative…